0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autoimmunity Reagents Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-19O9159
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Autoimmunity Reagents Market Outlook 2022
BUY CHAPTERS

Global Autoimmunity Reagents Market Research Report 2026

Code: QYRE-Auto-19O9159
Report
2026-02-13
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Autoimmunity Reagents Market Size

The global Autoimmunity Reagents market was valued at US$ 1728 million in 2025 and is anticipated to reach US$ 3132 million by 2032, at a CAGR of 9.0% from 2026 to 2032.

Autoimmunity Reagents Market

Autoimmunity Reagents Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Autoimmunity Reagents competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Autoimmune diseases refer to diseases caused by the body"s immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.
According to the regional perspective, the market of Autoimmunity Reagents can be divided into North America, Europe, Japan, China, etc. in 2019, the market share of Europe is the highest, accounting for about 43%, of which the Asia Pacific region is the main growth pole of the commodity consumption.
EUROIMMUN、HUMAN、Bio-Rad Laboratories are the key manufacturers in the Global Autoimmunity Reagents Production Market. Top 3 totally took up nearly 50% of the global market in 2019, among which EUROIMMUN is the leader with a market share of over 29%.
This report delivers a comprehensive overview of the global Autoimmunity Reagents market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Autoimmunity Reagents. The Autoimmunity Reagents market size, estimates, and forecasts are provided in terms of sales volume (K Unit) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Autoimmunity Reagents market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Autoimmunity Reagents manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Autoimmunity Reagents Market Report

Report Metric Details
Report Name Autoimmunity Reagents Market
Accounted market size in 2025 US$ 1728 million
Forecasted market size in 2032 US$ 3132 million
CAGR 9.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • BLOT
  • ELISA
  • IFA
  • CLIA
by Application
  • Hospital
  • Third-Party Testing Agency
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company EUROIMMUN, HUMAN, Bio-Rad Laboratories, AESKU, Inova, MBL, Orgentec, Trinity, Phadia, HOB Biotech, Shenzhen YHLO Biotech, Kangrun Biotech, Immuno-Biological Laboratories, Biomedical diagnostics, Shanghai Kexin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Autoimmunity Reagents manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Autoimmunity Reagents sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Autoimmunity Reagents Market growing?

Ans: The Autoimmunity Reagents Market witnessing a CAGR of 9.0% during the forecast period 2026-2032.

What is the Autoimmunity Reagents Market size in 2032?

Ans: The Autoimmunity Reagents Market size in 2032 will be US$ 3132 million.

What is the market share of major companies in Autoimmunity Reagents Market?

Ans: Top 3 totally took up nearly 50% of the global market in 2019, among which EUROIMMUN is the leader with a market share of over 29%.

Who are the main players in the Autoimmunity Reagents Market report?

Ans: The main players in the Autoimmunity Reagents Market are EUROIMMUN, HUMAN, Bio-Rad Laboratories, AESKU, Inova, MBL, Orgentec, Trinity, Phadia, HOB Biotech, Shenzhen YHLO Biotech, Kangrun Biotech, Immuno-Biological Laboratories, Biomedical diagnostics, Shanghai Kexin

What are the Application segmentation covered in the Autoimmunity Reagents Market report?

Ans: The Applications covered in the Autoimmunity Reagents Market report are Hospital, Third-Party Testing Agency

What are the Type segmentation covered in the Autoimmunity Reagents Market report?

Ans: The Types covered in the Autoimmunity Reagents Market report are BLOT, ELISA, IFA, CLIA

1 Autoimmunity Reagents Market Overview
1.1 Product Definition
1.2 Autoimmunity Reagents by Type
1.2.1 Global Autoimmunity Reagents Market Value by Type: 2025 vs 2032
1.2.2 BLOT
1.2.3 ELISA
1.2.4 IFA
1.2.5 CLIA
1.3 Autoimmunity Reagents by Application
1.3.1 Global Autoimmunity Reagents Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Third-Party Testing Agency
1.4 Global Autoimmunity Reagents Market Size Estimates and Forecasts
1.4.1 Global Autoimmunity Reagents Revenue 2021–2032
1.4.2 Global Autoimmunity Reagents Sales 2021–2032
1.4.3 Global Autoimmunity Reagents Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Autoimmunity Reagents Market Competition by Manufacturers
2.1 Global Autoimmunity Reagents Sales Market Share by Manufacturers (2021–2026)
2.2 Global Autoimmunity Reagents Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Autoimmunity Reagents Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Autoimmunity Reagents, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Autoimmunity Reagents, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Autoimmunity Reagents, Product Types and Applications
2.7 Global Key Manufacturers of Autoimmunity Reagents, Date of Entry into the Industry
2.8 Global Autoimmunity Reagents Market Competitive Situation and Trends
2.8.1 Global Autoimmunity Reagents Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Autoimmunity Reagents Players Market Share by Revenue
2.8.3 Global Autoimmunity Reagents Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Autoimmunity Reagents Market Scenario by Region
3.1 Global Autoimmunity Reagents Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Autoimmunity Reagents Sales by Region: 2021–2032
3.2.1 Global Autoimmunity Reagents Sales by Region: 2021–2026
3.2.2 Global Autoimmunity Reagents Sales by Region: 2027–2032
3.3 Global Autoimmunity Reagents Revenue by Region: 2021–2032
3.3.1 Global Autoimmunity Reagents Revenue by Region: 2021–2026
3.3.2 Global Autoimmunity Reagents Revenue by Region: 2027–2032
3.4 North America Autoimmunity Reagents Market Facts & Figures by Country
3.4.1 North America Autoimmunity Reagents Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Autoimmunity Reagents Sales by Country (2021–2032)
3.4.3 North America Autoimmunity Reagents Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Autoimmunity Reagents Market Facts & Figures by Country
3.5.1 Europe Autoimmunity Reagents Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Autoimmunity Reagents Sales by Country (2021–2032)
3.5.3 Europe Autoimmunity Reagents Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autoimmunity Reagents Market Facts & Figures by Region
3.6.1 Asia Pacific Autoimmunity Reagents Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Autoimmunity Reagents Sales by Region (2021–2032)
3.6.3 Asia Pacific Autoimmunity Reagents Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Autoimmunity Reagents Market Facts & Figures by Country
3.7.1 Latin America Autoimmunity Reagents Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Autoimmunity Reagents Sales by Country (2021–2032)
3.7.3 Latin America Autoimmunity Reagents Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autoimmunity Reagents Market Facts & Figures by Country
3.8.1 Middle East and Africa Autoimmunity Reagents Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Autoimmunity Reagents Sales by Country (2021–2032)
3.8.3 Middle East and Africa Autoimmunity Reagents Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autoimmunity Reagents Sales by Type (2021–2032)
4.1.1 Global Autoimmunity Reagents Sales by Type (2021–2026)
4.1.2 Global Autoimmunity Reagents Sales by Type (2027–2032)
4.1.3 Global Autoimmunity Reagents Sales Market Share by Type (2021–2032)
4.2 Global Autoimmunity Reagents Revenue by Type (2021–2032)
4.2.1 Global Autoimmunity Reagents Revenue by Type (2021–2026)
4.2.2 Global Autoimmunity Reagents Revenue by Type (2027–2032)
4.2.3 Global Autoimmunity Reagents Revenue Market Share by Type (2021–2032)
4.3 Global Autoimmunity Reagents Price by Type (2021–2032)
5 Segment by Application
5.1 Global Autoimmunity Reagents Sales by Application (2021–2032)
5.1.1 Global Autoimmunity Reagents Sales by Application (2021–2026)
5.1.2 Global Autoimmunity Reagents Sales by Application (2027–2032)
5.1.3 Global Autoimmunity Reagents Sales Market Share by Application (2021–2032)
5.2 Global Autoimmunity Reagents Revenue by Application (2021–2032)
5.2.1 Global Autoimmunity Reagents Revenue by Application (2021–2026)
5.2.2 Global Autoimmunity Reagents Revenue by Application (2027–2032)
5.2.3 Global Autoimmunity Reagents Revenue Market Share by Application (2021–2032)
5.3 Global Autoimmunity Reagents Price by Application (2021–2032)
6 Key Companies Profiled
6.1 EUROIMMUN
6.1.1 EUROIMMUN Company Information
6.1.2 EUROIMMUN Description and Business Overview
6.1.3 EUROIMMUN Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 EUROIMMUN Autoimmunity Reagents Product Portfolio
6.1.5 EUROIMMUN Recent Developments/Updates
6.2 HUMAN
6.2.1 HUMAN Company Information
6.2.2 HUMAN Description and Business Overview
6.2.3 HUMAN Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 HUMAN Autoimmunity Reagents Product Portfolio
6.2.5 HUMAN Recent Developments/Updates
6.3 Bio-Rad Laboratories
6.3.1 Bio-Rad Laboratories Company Information
6.3.2 Bio-Rad Laboratories Description and Business Overview
6.3.3 Bio-Rad Laboratories Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bio-Rad Laboratories Autoimmunity Reagents Product Portfolio
6.3.5 Bio-Rad Laboratories Recent Developments/Updates
6.4 AESKU
6.4.1 AESKU Company Information
6.4.2 AESKU Description and Business Overview
6.4.3 AESKU Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AESKU Autoimmunity Reagents Product Portfolio
6.4.5 AESKU Recent Developments/Updates
6.5 Inova
6.5.1 Inova Company Information
6.5.2 Inova Description and Business Overview
6.5.3 Inova Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Inova Autoimmunity Reagents Product Portfolio
6.5.5 Inova Recent Developments/Updates
6.6 MBL
6.6.1 MBL Company Information
6.6.2 MBL Description and Business Overview
6.6.3 MBL Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 MBL Autoimmunity Reagents Product Portfolio
6.6.5 MBL Recent Developments/Updates
6.7 Orgentec
6.7.1 Orgentec Company Information
6.7.2 Orgentec Description and Business Overview
6.7.3 Orgentec Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Orgentec Autoimmunity Reagents Product Portfolio
6.7.5 Orgentec Recent Developments/Updates
6.8 Trinity
6.8.1 Trinity Company Information
6.8.2 Trinity Description and Business Overview
6.8.3 Trinity Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Trinity Autoimmunity Reagents Product Portfolio
6.8.5 Trinity Recent Developments/Updates
6.9 Phadia
6.9.1 Phadia Company Information
6.9.2 Phadia Description and Business Overview
6.9.3 Phadia Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Phadia Autoimmunity Reagents Product Portfolio
6.9.5 Phadia Recent Developments/Updates
6.10 HOB Biotech
6.10.1 HOB Biotech Company Information
6.10.2 HOB Biotech Description and Business Overview
6.10.3 HOB Biotech Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 HOB Biotech Autoimmunity Reagents Product Portfolio
6.10.5 HOB Biotech Recent Developments/Updates
6.11 Shenzhen YHLO Biotech
6.11.1 Shenzhen YHLO Biotech Company Information
6.11.2 Shenzhen YHLO Biotech Description and Business Overview
6.11.3 Shenzhen YHLO Biotech Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolio
6.11.5 Shenzhen YHLO Biotech Recent Developments/Updates
6.12 Kangrun Biotech
6.12.1 Kangrun Biotech Company Information
6.12.2 Kangrun Biotech Description and Business Overview
6.12.3 Kangrun Biotech Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Kangrun Biotech Autoimmunity Reagents Product Portfolio
6.12.5 Kangrun Biotech Recent Developments/Updates
6.13 Immuno-Biological Laboratories
6.13.1 Immuno-Biological Laboratories Company Information
6.13.2 Immuno-Biological Laboratories Description and Business Overview
6.13.3 Immuno-Biological Laboratories Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolio
6.13.5 Immuno-Biological Laboratories Recent Developments/Updates
6.14 Biomedical diagnostics
6.14.1 Biomedical diagnostics Company Information
6.14.2 Biomedical diagnostics Description and Business Overview
6.14.3 Biomedical diagnostics Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Biomedical diagnostics Autoimmunity Reagents Product Portfolio
6.14.5 Biomedical diagnostics Recent Developments/Updates
6.15 Shanghai Kexin
6.15.1 Shanghai Kexin Company Information
6.15.2 Shanghai Kexin Description and Business Overview
6.15.3 Shanghai Kexin Autoimmunity Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Shanghai Kexin Autoimmunity Reagents Product Portfolio
6.15.5 Shanghai Kexin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autoimmunity Reagents Industry Chain Analysis
7.2 Autoimmunity Reagents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autoimmunity Reagents Production Mode & Process Analysis
7.4 Autoimmunity Reagents Sales and Marketing
7.4.1 Autoimmunity Reagents Sales Channels
7.4.2 Autoimmunity Reagents Distributors
7.5 Autoimmunity Reagents Customer Analysis
8 Autoimmunity Reagents Market Dynamics
8.1 Autoimmunity Reagents Industry Trends
8.2 Autoimmunity Reagents Market Drivers
8.3 Autoimmunity Reagents Market Challenges
8.4 Autoimmunity Reagents Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Autoimmunity Reagents Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Autoimmunity Reagents Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Autoimmunity Reagents Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Autoimmunity Reagents Sales (K Unit) of Key Manufacturers (2021–2026)
 Table 5. Global Autoimmunity Reagents Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Autoimmunity Reagents Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Autoimmunity Reagents Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Autoimmunity Reagents Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Autoimmunity Reagents, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Autoimmunity Reagents, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Autoimmunity Reagents, Product Types and Applications
 Table 12. Global Key Manufacturers of Autoimmunity Reagents, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Autoimmunity Reagents Companies by Tier (Tier 1, Tier 2, Tier 3), based on Autoimmunity Reagents Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Autoimmunity Reagents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Autoimmunity Reagents Sales by Region (K Unit), 2021–2026
 Table 18. Global Autoimmunity Reagents Sales Market Share by Region (2021–2026)
 Table 19. Global Autoimmunity Reagents Sales by Region (K Unit), 2027–2032
 Table 20. Global Autoimmunity Reagents Sales Market Share by Region (2027–2032)
 Table 21. Global Autoimmunity Reagents Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Autoimmunity Reagents Revenue Market Share by Region (2021–2026)
 Table 23. Global Autoimmunity Reagents Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Autoimmunity Reagents Revenue Market Share by Region (2027–2032)
 Table 25. North America Autoimmunity Reagents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Autoimmunity Reagents Sales by Country (K Unit), 2021–2026
 Table 27. North America Autoimmunity Reagents Sales by Country (K Unit), 2027–2032
 Table 28. North America Autoimmunity Reagents Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Autoimmunity Reagents Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Autoimmunity Reagents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Autoimmunity Reagents Sales by Country (K Unit), 2021–2026
 Table 32. Europe Autoimmunity Reagents Sales by Country (K Unit), 2027–2032
 Table 33. Europe Autoimmunity Reagents Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Autoimmunity Reagents Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Autoimmunity Reagents Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Autoimmunity Reagents Sales by Region (K Unit), 2021–2026
 Table 37. Asia Pacific Autoimmunity Reagents Sales by Region (K Unit), 2027–2032
 Table 38. Asia Pacific Autoimmunity Reagents Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Autoimmunity Reagents Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Autoimmunity Reagents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Autoimmunity Reagents Sales by Country (K Unit), 2021–2026
 Table 42. Latin America Autoimmunity Reagents Sales by Country (K Unit), 2027–2032
 Table 43. Latin America Autoimmunity Reagents Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Autoimmunity Reagents Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Autoimmunity Reagents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Autoimmunity Reagents Sales by Country (K Unit), 2021–2026
 Table 47. Middle East and Africa Autoimmunity Reagents Sales by Country (K Unit), 2027–2032
 Table 48. Middle East and Africa Autoimmunity Reagents Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Autoimmunity Reagents Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Autoimmunity Reagents Sales (K Unit) by Type (2021–2026)
 Table 51. Global Autoimmunity Reagents Sales (K Unit) by Type (2027–2032)
 Table 52. Global Autoimmunity Reagents Sales Market Share by Type (2021–2026)
 Table 53. Global Autoimmunity Reagents Sales Market Share by Type (2027–2032)
 Table 54. Global Autoimmunity Reagents Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Autoimmunity Reagents Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Autoimmunity Reagents Revenue Market Share by Type (2021–2026)
 Table 57. Global Autoimmunity Reagents Revenue Market Share by Type (2027–2032)
 Table 58. Global Autoimmunity Reagents Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Autoimmunity Reagents Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Autoimmunity Reagents Sales (K Unit) by Application (2021–2026)
 Table 61. Global Autoimmunity Reagents Sales (K Unit) by Application (2027–2032)
 Table 62. Global Autoimmunity Reagents Sales Market Share by Application (2021–2026)
 Table 63. Global Autoimmunity Reagents Sales Market Share by Application (2027–2032)
 Table 64. Global Autoimmunity Reagents Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Autoimmunity Reagents Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Autoimmunity Reagents Revenue Market Share by Application (2021–2026)
 Table 67. Global Autoimmunity Reagents Revenue Market Share by Application (2027–2032)
 Table 68. Global Autoimmunity Reagents Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Autoimmunity Reagents Price (USD/Unit) by Application (2027–2032)
 Table 70. EUROIMMUN Company Information
 Table 71. EUROIMMUN Description and Business Overview
 Table 72. EUROIMMUN Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. EUROIMMUN Autoimmunity Reagents Product
 Table 74. EUROIMMUN Recent Developments/Updates
 Table 75. HUMAN Company Information
 Table 76. HUMAN Description and Business Overview
 Table 77. HUMAN Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. HUMAN Autoimmunity Reagents Product
 Table 79. HUMAN Recent Developments/Updates
 Table 80. Bio-Rad Laboratories Company Information
 Table 81. Bio-Rad Laboratories Description and Business Overview
 Table 82. Bio-Rad Laboratories Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Bio-Rad Laboratories Autoimmunity Reagents Product
 Table 84. Bio-Rad Laboratories Recent Developments/Updates
 Table 85. AESKU Company Information
 Table 86. AESKU Description and Business Overview
 Table 87. AESKU Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. AESKU Autoimmunity Reagents Product
 Table 89. AESKU Recent Developments/Updates
 Table 90. Inova Company Information
 Table 91. Inova Description and Business Overview
 Table 92. Inova Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Inova Autoimmunity Reagents Product
 Table 94. Inova Recent Developments/Updates
 Table 95. MBL Company Information
 Table 96. MBL Description and Business Overview
 Table 97. MBL Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. MBL Autoimmunity Reagents Product
 Table 99. MBL Recent Developments/Updates
 Table 100. Orgentec Company Information
 Table 101. Orgentec Description and Business Overview
 Table 102. Orgentec Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Orgentec Autoimmunity Reagents Product
 Table 104. Orgentec Recent Developments/Updates
 Table 105. Trinity Company Information
 Table 106. Trinity Description and Business Overview
 Table 107. Trinity Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Trinity Autoimmunity Reagents Product
 Table 109. Trinity Recent Developments/Updates
 Table 110. Phadia Company Information
 Table 111. Phadia Description and Business Overview
 Table 112. Phadia Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Phadia Autoimmunity Reagents Product
 Table 114. Phadia Recent Developments/Updates
 Table 115. HOB Biotech Company Information
 Table 116. HOB Biotech Description and Business Overview
 Table 117. HOB Biotech Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. HOB Biotech Autoimmunity Reagents Product
 Table 119. HOB Biotech Recent Developments/Updates
 Table 120. Shenzhen YHLO Biotech Company Information
 Table 121. Shenzhen YHLO Biotech Description and Business Overview
 Table 122. Shenzhen YHLO Biotech Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Shenzhen YHLO Biotech Autoimmunity Reagents Product
 Table 124. Shenzhen YHLO Biotech Recent Developments/Updates
 Table 125. Kangrun Biotech Company Information
 Table 126. Kangrun Biotech Description and Business Overview
 Table 127. Kangrun Biotech Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Kangrun Biotech Autoimmunity Reagents Product
 Table 129. Kangrun Biotech Recent Developments/Updates
 Table 130. Immuno-Biological Laboratories Company Information
 Table 131. Immuno-Biological Laboratories Description and Business Overview
 Table 132. Immuno-Biological Laboratories Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Immuno-Biological Laboratories Autoimmunity Reagents Product
 Table 134. Immuno-Biological Laboratories Recent Developments/Updates
 Table 135. Biomedical diagnostics Company Information
 Table 136. Biomedical diagnostics Description and Business Overview
 Table 137. Biomedical diagnostics Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. Biomedical diagnostics Autoimmunity Reagents Product
 Table 139. Biomedical diagnostics Recent Developments/Updates
 Table 140. Shanghai Kexin Company Information
 Table 141. Shanghai Kexin Description and Business Overview
 Table 142. Shanghai Kexin Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. Shanghai Kexin Autoimmunity Reagents Product
 Table 144. Shanghai Kexin Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Autoimmunity Reagents Distributors List
 Table 148. Autoimmunity Reagents Customers List
 Table 149. Autoimmunity Reagents Market Trends
 Table 150. Autoimmunity Reagents Market Drivers
 Table 151. Autoimmunity Reagents Market Challenges
 Table 152. Autoimmunity Reagents Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Autoimmunity Reagents
 Figure 2. Global Autoimmunity Reagents Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Autoimmunity Reagents Market Share by Type: 2025 & 2032
 Figure 4. BLOT Product Picture
 Figure 5. ELISA Product Picture
 Figure 6. IFA Product Picture
 Figure 7. CLIA Product Picture
 Figure 8. Global Autoimmunity Reagents Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Autoimmunity Reagents Market Share by Application: 2025 & 2032
 Figure 10. Hospital
 Figure 11. Third-Party Testing Agency
 Figure 12. Global Autoimmunity Reagents Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Autoimmunity Reagents Market Size (US$ Million), 2021–2032
 Figure 14. Global Autoimmunity Reagents Sales (K Unit), 2021–2032
 Figure 15. Global Autoimmunity Reagents Average Price (USD/Unit), 2021–2032
 Figure 16. Autoimmunity Reagents Report Years Considered
 Figure 17. Autoimmunity Reagents Sales Share by Manufacturers in 2025
 Figure 18. Global Autoimmunity Reagents Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Autoimmunity Reagents Players: Market Share by Revenue in Autoimmunity Reagents in 2025
 Figure 20. Autoimmunity Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Autoimmunity Reagents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Autoimmunity Reagents Sales Market Share by Country (2021–2032)
 Figure 23. North America Autoimmunity Reagents Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Autoimmunity Reagents Sales Market Share by Country (2021–2032)
 Figure 27. Europe Autoimmunity Reagents Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Autoimmunity Reagents Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Autoimmunity Reagents Revenue Market Share by Region (2021–2032)
 Figure 35. China Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Taiwan Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Philippines Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Autoimmunity Reagents Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Autoimmunity Reagents Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Autoimmunity Reagents Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Autoimmunity Reagents Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Autoimmunity Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Autoimmunity Reagents by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Autoimmunity Reagents by Type (2021–2032)
 Figure 57. Global Autoimmunity Reagents Price (USD/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Autoimmunity Reagents by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Autoimmunity Reagents by Application (2021–2032)
 Figure 60. Global Autoimmunity Reagents Price (USD/Unit) by Application (2021–2032)
 Figure 61. Autoimmunity Reagents Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS